Welcome to our dedicated page for VICOR SEC filings (Ticker: VICR), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Vicor Corporation filings document the operating results, governance, and security structure of a NASDAQ-listed manufacturer of modular power components and complete power systems. Form 8-K reports furnish quarterly and annual financial-results press releases under Item 2.02, with exhibits and Inline XBRL cover data tied to product revenue, royalty revenue, licensing income, and related operating commentary.
Proxy and annual meeting filings cover director elections, executive compensation, equity award tables, pay-versus-performance data, and security-holder voting matters. The filings also describe the company's common stock registered under Section 12(b), the VICR trading symbol, and charter voting rights for Common Stock and Class B Common Stock.
VICOR CORP director Zmira Lavie received a grant of 548 non-qualified stock options for Common Stock. The options have an exercise price of $365.53 per share and were granted on June 22, 2026 under the company’s Amended and Restated 2000 Stock Option and Incentive Plan. They vest over a five-year period and expire on June 22, 2036. Following this award, Lavie holds 548 derivative securities of this type directly.
Vicor Corp director Zheng John Shen received a compensation-related equity grant. He was awarded a non-qualified stock option covering 548 shares of common stock at an exercise price of $365.53 per share, expiring on June 22, 2036. The option was granted under Vicor’s Amended and Restated 2000 Stock Option and Incentive Plan and vests over a five-year period, leaving him with 548 derivative securities following this grant.
VICOR CORP corporate vice president Claudio Tuozzolo reported an equity compensation grant and current holdings. He received a grant of 548.0000 Non Qualified Stock Options with a conversion or exercise price of 365.5300 per share, expiring on 2036-06-22 and linked to 548.0000 shares of Common Stock.
According to the footnote, these options were granted under the Companys Amended and Restated 2000 Stock Option and Incentive Plan on June 22, 2026 and vest over a five year period. A separate holding entry shows 13240.0000 shares of Common Stock held directly following the reported transactions.
VICR: Multiple proposed sales of common shares reported on Form 144. The filing lists numerous 10b5-1 sales attributed to Patrizio Vinciarelli and several institutionally named holders, showing individual sale transactions (for example, 20,000 shares on multiple June 2026 dates and 50,000 shares on 04/15/2026). The entries identify trade dates and share counts for each planned sale.
Vicor Corporation reported the results of its 2026 Annual Meeting of Stockholders held on June 19, 2026. Stockholders approved fixing the board at eleven members and elected all eleven director nominees, each receiving over 131 million votes in favor and relatively few votes withheld.
Stockholders also approved, on an advisory basis, the compensation of the company’s named executive officers as described in the 2026 proxy statement, with 143,003,631 votes for, 347,218 votes against and 48,770 abstentions. There were no broker non-votes on either proposal.
VICOR CORP CFO James F. Schmidt reported an exercise-and-sell transaction in company stock. He exercised options to acquire 2,124 shares of common stock at strike prices of $32.89 and $44.07 per share, then sold the same 2,124 shares in multiple open-market trades under a Rule 10b5-1 trading plan at prices between $351.38 and $367.12 per share. Following these transactions, he holds no common shares directly but was granted 548 non‑qualified stock options with an exercise price of $365.53 per share expiring on June 22, 2036.
Vicor (VICR) related resale notices list multiple proposed or completed sales of Common stock by affiliated holders and brokers. The excerpt shows repeated 10b5-1 sales by PATRIZIO VINCIARELLI on numerous dates in March–June 2026, with individual lot sizes (e.g., 20,000; 50,000; 40,000 shares) and dollar proceeds recorded alongside each trade date.
The filing also lists broker/dealer information (Morgan Stanley Smith Barney LLC) and specific institution entries (Brigham and Women's Hospital; Lahey Hospital & Medical Center) with share quantities and proceeds on particular dates.
The filing reports a Rule 144 sale related entry: 4,209 shares of Common Stock were sold on 06/22/2026 following an exercise of stock options with the counterparty listed as the Issuer and payment by cash. The filing also lists prior 10b5-1 sales by James Schmidt: 5,000 shares on 06/01/2026 for $1,609,125.50, 4,274 shares on 05/04/2026 for $1,080,961.27, and 1,241 shares on 04/27/2026 for $343,757.00.
VICOR CORP Chairman & CEO Patrizio Vinciarelli reported open-market sales of 20,000 shares of common stock on June 18, 2026. The shares were sold in multiple transactions at weighted-average prices between $324.2950 and $340.1000 under a pre-arranged Rule 10b5-1 trading plan adopted on February 26, 2026.
Following these sales, he holds 8,528,090 VICOR CORP shares directly and 167,125 shares indirectly as trustee of an irrevocable trust established for the benefit of his child.
Issuer filed Form 144 reporting multiple dispositions of Common Stock under pre-arranged plans. The filings list numerous 10b5-1 sales by Patrizio Venciarelli and others: repeated daily sales of 20,000 shares across June 1–17, 2026, and larger earlier blocks (e.g., 50,000 shares on 04/15/2026). The form lists a separate Founders Shares line showing 20,000 shares.